Wellington Management Group
KRTX

Wellington Management Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Wellington Management Group’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,134,046
Closed -$359M – 1998
2023
Q4 		$359M Sell
1,134,046
-151,462
-12% -$29.4M 0.07% 275
2023
Q3 		$217M Sell
1,285,508
-114,729
-8% -$21.6M 0.04% 347
2023
Q2 		$304M Sell
1,400,237
-206,617
-13% -$44.3M 0.06% 301
2023
Q1 		$292M Buy
1,606,854
+551,778
+52% +$106M 0.06% 310
2022
Q4 		$207M Buy
1,055,076
+53,973
+5% +$11.6M 0.04% 378
2022
Q3 		$225M Buy
1,001,103
+62,954
+7% +$12.7M 0.05% 351
2022
Q2 		$119M Buy
938,149
+84,812
+10% +$9.75M 0.02% 499
2022
Q1 		$108M Sell
853,337
-141,202
-14% -$15.9M 0.02% 567
2021
Q4 		$130M Sell
994,539
-7,347
-0.7% -$950K 0.02% 567
2021
Q3 		$123M Buy
1,001,886
+55,305
+6% +$6.38M 0.02% 568
2021
Q2 		$108M Buy
946,581
+289,685
+44% +$33.9M 0.02% 609
2021
Q1 		$79M Buy
656,896
+523,865
+394% +$59.3M 0.01% 677
2020
Q4 		$13.5M Buy
+133,031
New +$12.3M ﹤0.01% 1111
2019
Q3 		– Sell
-28,031
Closed -$561K – 2141
2019
Q2 		$561K Buy
+28,031
New +$561K ﹤0.01% 1886

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Wellington Management Group's KRTX Position: Q1 2024 in Review

Wellington Management Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 1,134,046 shares — an estimated $359M sold.

Wellington Management Group first reported a position in KRTX in Q2 2019 and held it in 14 quarters. The position peaked at $359M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Wellington Management Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Wellington Management Group sold 1,134,046 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $359M.
  • Wellington Management Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2019 and held it in 14 quarters.
  • Wellington Management Group's Karuna Therapeutics, Inc. Common Stock position peaked at $359M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Wellington Management Group's 13F filing for Q1 2024, filed 15 May 2024.